Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Magnesium Sulphate: Inj Magnesium Sulphate 250mg added to Inj Bupivacaine 0.5% 20ml
Duration of study is 1 year 6 months
Control Intervention1: Tramadol: Inj Tramadol 100mg added to Inj
Sponsors
Dr Vartika Bhargava
Eligibility
Inclusion criteria
Inclusion criteria: ASA status class1 or class 2 Elective upper limb surgery
Exclusion criteria
Exclusion criteria: Patient refusal Coagulation disorders ASA status of class 3 or class 4 History of allergy to drug Local infection at block site Existing neurological disorder/nerve palsy/psychiatric/neuromuscular/cardiovascular/pulmonary/renal or hepatic impairment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the efficacy of injection Magnesium Sulphate (250mg) versus injection Tramadol (100mg) as an adjuvant to injection Bupivacaine 0.5% (20ml) in supraclavicular brachial plexus block.Timepoint: Duration of analgesia in first 24hrs assessed by VAS scoring | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To observe and compare onset and duration of sensory and motor blockade. 2.To observe and compare duration of postoperative analgesia. 3.To observe perioperative hemodynamic changes, side effects and complications like Hypotension, Bradycardia, Neurovascular Injury. Timepoint: 24 hours | — |
Countries
India
Contacts
Public ContactDr Raghavendra Babu T
JSS Hospital
Outcome results
None listed